A septal occlusion device for closing an abnormal opening in the heart includes a wire mesh support structure with a first disk, a second disk, and a waist portion joining the first and second disk; and a thin-film micromesh coupled to the wire mesh and configured to extend across the abnormal opening. A left arterial appendage (LAA) occlusion device for sealing an LAA in the heart includes a support structure having a plurality of struts extending radially from a center to a distal portion to form a substantially hemisphere or dome shape, the distal portion of each strut being configured to engage an interior wall of the left arterial appendage, and a thin-film micromesh cover attached to the support structure and configured to extend across the opening of the left arterial appendage.

An example closure device is disclosed. The closure device includes a framework including a first end region, a second end region and a medial region extending therebetween. The medical device also includes a biodegradable tissue ingrowth member extending over at least a portion of the framework, wherein the tissue ingrowth member is configured to promote tissue ingrowth thereupon, and wherein the tissue ingrowth is configured to seal an opening in the heart.

A system for treating tissue includes a clip assembly including a pair of clip arms, each of the clip arms extending from a proximal end to a distal end, the proximal end of the clip arms connected to one another via a central member slidably received within a channel of a capsule to be moved between a tissue receiving configuration and a closed configuration, a cartridge for encasing the clip assembly including a groove formed therein to accommodate the clip assembly and an opening extending thereinto in communication with a portion of the groove such that the groove is open to an exterior of the cartridge via the opening, and an applicator releasably connectable to the clip assembly to move the clip assembly between the open and closed configurations, a distal portion of the applicator insertable through the opening of the cartridge to be connected to the clip assembly.

Apparatus for sealing a vascular wall penetration disposed at the end of the tissue tract comprises a shaft, an occlusion element, a hemostatic implant, and a protective sleeve. The apparatus is deployed through the tissue tract with the occlusion element temporarily occluding the vascular wall penetration and inhibiting backbleeding therethrough. The hemostatic implant, which will typically be a biodegradable polymer such as collagen carrying an anti-proliferative agent or coagulation promoter, will then be deployed from the sealing apparatus and left in place to enhance closure of the vascular wall penetration with minimum scarring. The implant may be radiopaque to allow observation before release.

Disclosed herein are improved methods and apparatuses for providing hemostasis within a cavity defined by an internal surface of a bleeding tissue space. A catheter comprising a proximal end and a distal end may be advanced into the cavity through a proximal opening of the tissue space into the cavity. A distal balloon coupled to the catheter may be positioned adjacent a distal opening of the tissue space, and expanded to seal the distal opening. A hemostatic agent may be applied from the catheter to the internal surface of the tissue space to inhibit bleeding of the tissue space. The hemostatic agent may be applied without occluding the proximal opening, the distal opening, and a path extending therebetween with the hemostatic agent.

The invention encompasses devices and methods used to provide wound closure based on rings positioned within the tissue layers of the wound opening (with the rings regionally separate the wound depth tissue layers into 2 compartments), followed by suture transport through the rings and full-thickness tissue layers of both compartments. Upon suture transport via synchronous or asynchronous manner and device removal, wound closure is achieved by tying the 2 ends of the suture without incorporating tissue above the level of the rings such as skin. When the device is applied to abdominal or chest wall wound opening, all tissue layers except the skin are incorporated in the suture closure of the wound. The closure process can be performed in a simple, reliable, and expeditious manner.

Multiple vascular wall penetrations are formed and sealed in a single blood vessel, typically a vein, for performing cardiac and other catheter-based procedures. Access sheaths are placed in two or more tissue tracts each having a vascular wall penetration at a distal end and into a lumen of the blood vessel. A catheter is advanced though each of the access sheaths to perform a therapeutic or diagnostic procedure. A vascular closure device is introduced through each access sheath, typically sequentially, and an occlusion element at a distal end of the device is deployed against an inner wall of the blood vessel in a manner so that the adjacent access sheath does not interfere or overlap with the deployed occlusion element. The vascular penetration at the distal end in that tissue tract may then be sealed prior to using another vascular closure device to seal a caudally adjacent vascular wall penetration.

Devices, kits, and methods of delivering a plurality of strips to a tissue defect site to promote covering and/or closure of the tissue defect are described. The kit may include a first medical device configured to push the plurality of strips housed therein through a distal opening and a second medical device defining a working channel for insertion of the first medical device. Methods may include introducing a distal portion of a medical device housing a plurality of strips that include a biocompatible material into a gastrointestinal tract, positioning the distal portion of the device proximate a target site of a tissue wall of the gastrointestinal tract that includes a defect, and applying the plurality of strips to the target site by pushing the plurality of strips out of a distal opening of the device.

A medical device configured to be percutaneously delivered to a heart with a catheter of a medical device delivery system. The medical device including a framework and tissue growth member. The framework includes a hub with frame segments extending radially from the hub. The tissue growth member is attached to the framework and extends radially along the framework such that the tissue growth member extends to define an outer layer portion and an inner layer portion where the framework is coupled to the inner layer portion. Further, the tissue growth member extends with multiple voids defined therein such that a filler material is configured to temporarily fill the multiple voids of the tissue growth member.

An embodiment of the present disclosure a bioabsorbable occlusion system for occluding defects or openings in a heart.